| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/23/2002 | WO2002040683A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/23/2002 | WO2002040682A1 Process for producing coenzyme q¿10? |
| 05/23/2002 | WO2002040681A1 The polypeptide fragments of hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits |
| 05/23/2002 | WO2002040680A2 Death domain proteins |
| 05/23/2002 | WO2002040679A2 Corynebacterium glutamicum promoters |
| 05/23/2002 | WO2002040678A1 Small acid-soluble spore protein and uses thereof |
| 05/23/2002 | WO2002040677A2 Cotton event pv-ghbk04 (531) and compositions and methods for detection thereof |
| 05/23/2002 | WO2002040676A2 Mutant allergens |
| 05/23/2002 | WO2002040675A1 Novel human tumor necrosis factor mutant proteins and their preparing methods and uses |
| 05/23/2002 | WO2002040674A2 '67118', '67067' and '62092', human proteins and methods of use thereof |
| 05/23/2002 | WO2002040673A2 Compositions and methods relating to lung specific genes and proteins |
| 05/23/2002 | WO2002040672A2 Compositions and methods relating to breast specific genes and proteins |
| 05/23/2002 | WO2002040671A2 Immunoglobulin superfamily proteins |
| 05/23/2002 | WO2002040670A2 A human g-protein coupled receptor, hgprbmy8, expressed hig hly in brain |
| 05/23/2002 | WO2002040669A1 Novel guanosine triphosphate (gtp) binding protein-coupled receptor protein, bg37 |
| 05/23/2002 | WO2002040668A2 Proteins and dna sequences underlying these proteins used for treating inflammations |
| 05/23/2002 | WO2002040667A1 Method of diagnosing and treating lesion of crystalline lens using human crygs gene and coding product thereof |
| 05/23/2002 | WO2002040666A2 Fat regulated genes, uses thereof, and compounds for modulating same |
| 05/23/2002 | WO2002040665A2 Complementing cell lines |
| 05/23/2002 | WO2002040664A1 Method of constructing nucleic acid library |
| 05/23/2002 | WO2002040663A1 Nucleic acids for detecting fungi and method of detecting fungi by using the same |
| 05/23/2002 | WO2002040662A2 Transgenic mice containing targeted gene disruptions |
| 05/23/2002 | WO2002040661A2 TRANSGENIC MICE CONTAINING Kir2.3 POTASSIUM K+ CHANNEL GENE DISRUPTIONS |
| 05/23/2002 | WO2002040660A2 Promoter for the functional characterisation of g-protein coupled receptors in the yeast saccharomyces cerevisiae |
| 05/23/2002 | WO2002040659A1 POLYPEPTIDES HAVING α-ISOMALTOSYL TRANSFERASE ACTIVITY |
| 05/23/2002 | WO2002040658A2 Isomerases |
| 05/23/2002 | WO2002040656A2 47476, 67210, 49875, 46842, 33201, 83378, 84233, 64708, 85041, and 84234, novel human guanine nucleotide dissociation stimulator, glycosyltransferase, dead type helicase, centaurin, dehydrogenase/reductase, and metal transporter family members and uses thereof |
| 05/23/2002 | WO2002040655A2 Phospholipase a2 group preferentially expressed in th2 cells |
| 05/23/2002 | WO2002040652A2 Novel soluble endoproteases for the in vitro processing of recombinant proteins |
| 05/23/2002 | WO2002040651A2 A human trna-specific adenosine deaminase |
| 05/23/2002 | WO2002040650A2 Methods for large scale production of recombinant dna-derived tpa or k2s molecules |
| 05/23/2002 | WO2002040649A1 Slo2 and slo4, novel potassium channel proteins from human brain |
| 05/23/2002 | WO2002040641A2 Binary bac vector and uses thereof |
| 05/23/2002 | WO2002040637A2 Antisense modulation of pi3k p85 expression |
| 05/23/2002 | WO2002040636A2 Modification of a plant disease resistance gene specificity and method for engineering altered specificity |
| 05/23/2002 | WO2002040633A2 Optimized antitrypsin expression in rice cell culture |
| 05/23/2002 | WO2002040632A2 Creation and identification of proteins having new dna binding specificities |
| 05/23/2002 | WO2002040629A2 Promoters exhibiting endothelial cell specificity and methods of using same |
| 05/23/2002 | WO2002040544A2 Mutant human factor ix with an increased resistance to inhibition by heparin |
| 05/23/2002 | WO2002040542A2 58569 and 50111, human anion exchange proteins and methods of use thereof |
| 05/23/2002 | WO2002040541A2 Transporters and ion channels |
| 05/23/2002 | WO2002040540A2 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor |
| 05/23/2002 | WO2002040539A2 Gpcr-like protein and nucleic acids encoding same |
| 05/23/2002 | WO2002040538A2 Regulation of human nmda receptor |
| 05/23/2002 | WO2002040535A2 Compositions and methods relating to ovary specific genes and proteins |
| 05/23/2002 | WO2002040532A1 A new polypeptide-prostatic gland specific membrane antigen 9 and the polynucleotide encoding it |
| 05/23/2002 | WO2002040531A1 Lapemis hardwicki short chain neurotoxin and gene encoding it |
| 05/23/2002 | WO2002040528A1 A method of producing non-natural silk by bombyx mori |
| 05/23/2002 | WO2002040527A1 A novel lapemis hardwicki phosphatidase a2 and gene encoding said polypeptide |
| 05/23/2002 | WO2002040526A1 A novel polypeptide-homo brain specific expressed protein 18.70 and polynucleotide encoding said polypeptide |
| 05/23/2002 | WO2002040525A1 A novel polypeptide-homo zinc finger protein 18.92 and polynucleotide encoding said polypeptide |
| 05/23/2002 | WO2002040524A1 A NOVEL POLYPEPTIDE-HOMO aFGF CONJUGATED FACTOR 10.78 AND POLYNUCLEOTIDE ENCODING SAID POLYPEPTIDE |
| 05/23/2002 | WO2002040523A1 A NOVEL POLYPEPTIDE-HOMO GLUTARYL- CoA DEHYDROGENASE 15.51 AND POLYNUCLEOTIDE ENCODING SAID POLYPEPTIDE |
| 05/23/2002 | WO2002040522A1 A NOVEL POLYPEPTIDE-HOMO TRANSCRIPTION GROWTH REGULATORY FACTOR β ACTIVATION PROTEIN 14.08 AND POLYNUCLEOTIDE ENCODING SAID POLYPEPTIDE |
| 05/23/2002 | WO2002040521A1 A novel polypeptide-homo dna-dependent rna polymerase ac40 subunit inhibitor 9.68 and polynucleotide encoding said polypeptide |
| 05/23/2002 | WO2002040518A1 Periplasmic domain of an enterobacterium omp protein and its use as carrier or adjuvant |
| 05/23/2002 | WO2002040517A2 M. tuberculosis chaperonin 60.1 and uses thereof |
| 05/23/2002 | WO2002040515A2 Exoenzyme toxin of aeromonas salmonicida, and uses thereof |
| 05/23/2002 | WO2002040514A2 Type iii secretion pathway in aeromonas salmonicida, and uses therefor |
| 05/23/2002 | WO2002040512A2 Human beta-defensin-3 |
| 05/23/2002 | WO2002040511A2 Dna sequence and microcine from escherichia coli strain dsm 6601 |
| 05/23/2002 | WO2002040506A2 Modified clostridial neurotoxins with altered biological persistence |
| 05/23/2002 | WO2002040504A2 Sol-fusin: use of gp64-6his to catalyze membrane fusion |
| 05/23/2002 | WO2002040503A2 Haplotypes of the plau gene |
| 05/23/2002 | WO2002040502A2 Haplotypes of the lipe gene |
| 05/23/2002 | WO2002040501A2 Membrane scaffold proteins |
| 05/23/2002 | WO2002040499A1 A method for generating genetically altered antigens |
| 05/23/2002 | WO2002040498A2 Reduction of antioxidant enzyme levels in tumor cells using antisense oligonucleotides |
| 05/23/2002 | WO2002040130A1 Liquid chromatographic separation of polynucleotides |
| 05/23/2002 | WO2002040059A2 Methods and compositions for inducing cell-mediated immune responses |
| 05/23/2002 | WO2002040046A1 Salmonella vaccine |
| 05/23/2002 | WO2002040038A2 M. tuberculosis chaperonin 10 and uses thereof |
| 05/23/2002 | WO2002040037A2 M. tuberculosis chaperonin 60.1 and uses thereof |
| 05/23/2002 | WO2002039955A2 Biodegradable mixed polymeric micelles for drug delivery |
| 05/23/2002 | WO2002039923A2 Inhibition of alpha-2 hs glycoprotein (ahsg/fetuin) in obesity and insulin control of glucose homeostasis |
| 05/23/2002 | WO2002039885A2 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 05/23/2002 | WO2002039813A1 Pd-1-lacking mouse and use thereof |
| 05/23/2002 | WO2002039809A2 Regulation of flavonoid expression in alfalfa using maize regulatory genes |
| 05/23/2002 | WO2002039808A1 Method of enhancing virus-resistance in plants and producing virus-immune plants |
| 05/23/2002 | WO2002016562A3 22244 and 8701, novel human dehydrogenases and uses thereof |
| 05/23/2002 | WO2002015931A9 Immunologic method for the prevention of dental caries |
| 05/23/2002 | WO2002006324A3 Antifungal and/or antibacterial peptides, preparation methods and composition containing same |
| 05/23/2002 | WO2002004609A3 Mutations of cryptic splice sites in cre and cre fused proteins for improvement of expression and inducibility |
| 05/23/2002 | WO2002004595A3 Production of chimeric human papillomavirus |
| 05/23/2002 | WO2002003911B1 Prevention and treatment of alzheimer's disease |
| 05/23/2002 | WO2002002779A3 Nucleotide sequences which encode the plsc protein |
| 05/23/2002 | WO2002000991A9 Method for improving transfection efficiency |
| 05/23/2002 | WO2001096603A3 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions |
| 05/23/2002 | WO2001096595A3 Method for the detection of influenza a/b viruses in saliva |
| 05/23/2002 | WO2001096551A3 Whole cell engineering by mutagenizing a substantial portion of a starting genome, combining mutations, and optionally repeating |
| 05/23/2002 | WO2001095860A3 Probes for chondrogenesis |
| 05/23/2002 | WO2001094603A3 Method of using dna episomes to suppress gene expression in plants |
| 05/23/2002 | WO2001094003A3 Method and apparatus for washing and drying pins in microarray spotting instruments |
| 05/23/2002 | WO2001092552A3 Method for the purification of alphavirus replicon particles |
| 05/23/2002 | WO2001092484A3 Adjuvant preparation for the induction of specific immunity |
| 05/23/2002 | WO2001092313A3 Methods for isolating and using fungal hemolysins |
| 05/23/2002 | WO2001088117A3 In vitro fucosylation recombinant glycopeptides |
| 05/23/2002 | WO2001088103A9 Compositions and methods for tissue dedifferentiation and regeneration |
| 05/23/2002 | WO2001087976A3 Gpcr 4-helix and 5-helix bundles |
| 05/23/2002 | WO2001087884A3 Polyketide derivatives |